Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute strokeCamilla Hesse, Kaj Blennow, Lars Rosengren et al.|Neuroscience Letters|2001Cited by 452
Simultaneous Measurement of β-Amyloid(1–42), Total Tau, and Phosphorylated Tau (Thr181) in Cerebrospinal Fluid by the xMAP TechnologyAnnika Olsson, Kaj Blennow, Hugo Vanderstichele et al.|Clinical Chemistry|2004Cited by 441
CSF biomarker variability in the Alzheimer's Association quality control programNiklas Mattsson, Olivier Bousiges, Ulf Andréasson et al.|Alzheimer s & Dementia|2013Cited by 386
Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathologyInge M.W. Verberk, Charlotte E. Teunissen, Bart N.M. van Berckel et al.|Alzheimer s Research & Therapy|2020Cited by 274
Cerebrospinal Fluid Markers for Alzheimer's Disease Evaluated after Acute Ischemic StrokeCamilla Hesse, Kaj Blennow, Lars Rosengren et al.|Journal of Alzheimer s Disease|2000Cited by 212